Novartis and Google to develop ’smart’ contact lens
Source: thestar.com
‘The promise here is the Holy Grail of vision care, to be able to replicate the natural functioning of the eye,’ says Novartis CEO Joe Jimenez
Inc. gained an ally to develop smart contact lenses with embedded electronics to improve vision and monitor health by teaming up with Swiss drug company Novartis AG.
Novartis’s Alcon unit will work with Google’s secretive Google X division on lenses with non-invasive sensors, microchips and embedded miniaturized electronics to monitor insulin levels for people with diabetes, or to restore the eye’s natural focus in people who can no longer read without glasses, Basel-based Novartis said in a statement Tuesday. No terms of the deal were disclosed.
Novartis chief executive officer Joe Jimenez identified eye care as one of three key divisions, along with branded and generic drugs, in announcing a $28.5 billion restructure of the company in April that involved selling off the vaccines and animal-health units and buying GlaxoSmithKline PLC’s cancer business.
“The promise here is the Holy Grail of vision care, to be able to replicate the natural functioning of the eye,” Jimenez said Tuesday.
“Think about a contact lens that could help the eye autofocus on that newspaper and then when you look up it would autofocus in the distance.
“This is a key step for us to go beyond the confines of traditional disease management, starting with the eye,” Jimenez said in a statement released with the announcement.
At a meeting with analysts and investors last month, Jimenez said technology would become more important in pharmaceuticals as patients take a more active role in their own health care.
“If you think about the convergence of biology and micro- processing today and things like remote patient monitoring and there can be a breakthrough in innovation that can help manage this aging population and this is going to be the key,” Jimenez said.
[...]
Read the full article at: thestar.com
